menu
    • menu

    Company profile for Medicenna Therapeutics

    NEW Drugs in Dev: 6
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    As a CDMO, Mikart offers integrated CDMO services for Solid Dose & Non-sterile Liquid formulations.

    Virtual Booth

    Contact Supplier

    Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming he...
    Medicenna is a clinical stage immunooncology company advancing novel, highly selective versions of IL-2, IL-4 and IL-13 Superkines™ and first in class Empowered Cytokines™. We are developing a unique set of tunable Superkines™ that can be fused with pro-apoptotic proteins to precisely deliver potent cell-killing agents to cancer cells, the immunosuppressive tumor micro-environment and cancer stem cells without harming healthy cells.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Medicenna TherapeuticsCanada Flag
    Country
    Country
    Canada
    Address
    Address
    1920 Yonge St Toronto, Ontario, CA
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.medicenna.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/medicenna-therapeutics-corp.
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/medicenna1?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    RDD

    RDD

    Not Confirmed

    envelop Contact Supplier

    RDD

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Medicenna, Fondazione Melanoma Onlus Present NEOCYT Trial
    Medicenna, Fondazione Melanoma Onlus Present NEOCYT Trial

    30 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/30/3284740/0/en/medicenna-and-fondazione-melanoma-onlus-announce-presentation-on-neocyt-trial-at-asco-2026.html

    GLOBENEWSWIRE
    30 Apr 2026
    Share Share
    Medicenna Unveils Superior MDNA113 Data at AACR 2026
    Medicenna Unveils Superior MDNA113 Data at AACR 2026

    21 Apr 2026

    // FIRSTWORD PHARMA

    https://firstwordpharma.com/story/7199074

    FIRSTWORD PHARMA
    21 Apr 2026
    Share Share
    Medicenna to Present at 2026 Bloom Burton Investor Conference
    Medicenna to Present at 2026 Bloom Burton Investor Conference

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273234/0/en/Medicenna-to-Present-at-the-2026-Bloom-Burton-Co-Healthcare-Investor-Conference.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    Medicenna Appoints Dr. Nageatte Ibrahim Chief Medical Officer
    Medicenna Appoints Dr. Nageatte Ibrahim Chief Medical Officer

    09 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/09/3270800/0/en/Medicenna-Therapeutics-Appoints-Dr-Nageatte-Ibrahim-as-Chief-Medical-Officer.html

    GLOBENEWSWIRE
    09 Apr 2026
    Share Share
    Medicenna To Present Anti-PD-1 IL-2 Superkine Data At AACR 2026
    Medicenna To Present Anti-PD-1 IL-2 Superkine Data At AACR 2026

    18 Mar 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/03/18/3258064/0/en/Medicenna-to-Present-Preclinical-Data-from-its-First-in-Class-Tumor-Anchored-and-Conditionally-Activated-Anti-PD-1-IL-2-Bifunctional-Superkine-at-the-AACR-Annual-Meeting-2026.html

    GLOBENEWSWIRE
    18 Mar 2026
    Share Share
    Medicenna Therapeutics To Participate In Future Conferences
    Medicenna Therapeutics To Participate In Future Conferences

    18 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/18/3240097/0/en/Medicenna-Therapeutics-Announces-Participation-in-Upcoming-Conferences.html

    GLOBENEWSWIRE
    18 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search